HIF1A and Alzheimer disease: Our study uncovers a key role of RNF20 in safeguarding genome integrity as well as inhibiting EMT and metabolic rewiring in lung epithelial and neuroendocrine cells and points to HIF1α inhibition as a potential therapeutic strategy for AD and SCLC patients with decreased RNF20 function (Fig. 10c).